ArticleGels (Basel, Switzerland)2025
Eugenol@natural Zeolite vs. Citral@natural Zeolite Nanohybrids for Gelatin-Based Edible-Active Packaging Films.
Article in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, aligned with the principles of the circular economy and sustainability, novel eugenol@natural zeolite (EG@NZ) and citral@natural zeolite (CT@NZ) nanohybrids were developed. These nanohybrids were successfully incorporated into a pork gelatin (Gel)/glycerol (Gl) composite matrix using an extrusion-compression molding method to produce innovative active packaging films: Gel/Gl/xEG@NZ (where x = 5, 10, and 15%wt.) and Gel/Gl/xCT@NZ (where x = 5 and 10%wt.). All films exhibited zero oxygen barrier properties. Release kinetic studies showed that both EG@NZ and CT@NZ nanohybrids adsorbed up to 58%wt. of their respective active compounds. However, EG@NZ exhibited a slow and nearly complete release of eugenol, whereas CT@NZ released approximately half of its citral content at a faster rate. Consequently, the obtained Gel/Gl/xEG@NZ films demonstrated significantly higher antioxidant activity as measured by the 2,2-diphenyl-1-picrylhydrazylradical (DPPH) assay and superior antibacterial effectiveness against
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.